Skip to content
10-Q

Quarterly Report

GREENWICH LIFESCIENCES, INC. GLSI

0001493152-26-027150

← back to feed
Filed
Jun 4, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 26, 2026 14.68M sh
Shares Diluted Q1 2026 · Mar 31, 2026 14.57M sh
Shares Diluted Q1 2026 · Mar 31, 2025 13.17M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$4.7M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.83M
Stockholders Equity Q1 2026 · Mar 31, 2026 $5.27M
Stockholders Equity Q1 2026 · Dec 31, 2025 $353.22K
Stockholders Equity restated Q1 2026 · Mar 31, 2025 $200.48K
Stockholders Equity restated Q1 2026 · Dec 31, 2024 $908.63K
Current Liabilities Q1 2026 · Mar 31, 2026 $5.24M
Current Liabilities Q1 2026 · Dec 31, 2025 $5.82M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.24M
Total Liabilities Q1 2026 · Dec 31, 2025 $5.82M
Current Assets Q1 2026 · Mar 31, 2026 $10.51M
Current Assets Q1 2026 · Dec 31, 2025 $6.18M
Total Assets Q1 2026 · Mar 31, 2026 $10.51M
Total Assets Q1 2026 · Dec 31, 2025 $6.18M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.39
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$0.21
Eps Basic Q1 2026 · Mar 31, 2026 −$0.39
Eps Basic restated Q1 2026 · Mar 31, 2025 −$0.21
Sga Expense Q1 2026 · Mar 31, 2026 $518.19K
Sga Expense restated Q1 2026 · Mar 31, 2025 $497.6K
Rd Expense Q1 2026 · Mar 31, 2026 $5.21M
Rd Expense restated Q1 2026 · Mar 31, 2025 $2.27M
Net Income Q1 2026 · Mar 31, 2026 −$5.66M
Net Income restated Q1 2026 · Mar 31, 2025 −$2.74M
Operating Income Q1 2026 · Mar 31, 2026 −$5.73M
Operating Income restated Q1 2026 · Mar 31, 2025 −$2.77M